Posts Tagged "Stephan Schuerer"

The Library of Integrated Network-Based Cellular Signatures (LINCS) is an NIH Common Fund program with the goal of generating a large-scale and comprehensive catalogue of perturbation-response signatures by utilizing a diverse collection of: Perturbations (e.g. chemical, genetic, disease state) Model Systems (e.g. cell lines, differentiated cells, embryonic stem cells) and Sssay Types (e.g. gene expression, protein expression,...

If you build it, the data will not only come, it will be standardized, accessible, and reusable by researchers around the world. With this in mind, the National Institutes of Health (NIH) is creating its Data Commons initiative, and recently invited University of Miami investigators to contribute their expertise. "There is a big effort at the NIH now to bring biomedical research into the data science era. Data science including...

It’s part genomics*, part big data, and all about driving discoveries that could someday translate to new treatments for cancer, neurological diseases, addiction, and many other conditions, said Stephan Schürer, Ph.D.,  CCS Drug Discovery program director, and associate professor of molecular and cellular pharmacology at the UM Miller School of Medicine. The NIH’s "Illuminating the Druggable Genome" (IDG) initiative is expected to...

Join Mark Musen (Stanford), Janice Kranz and Stephan Schürer (University of Miami) for CDD’s Q3 Town Hall Webinar, “Human vs. Machine-Enhanced Scientific Discovery” Listen Here We’re seeing ‘Big Data’ everywhere: healthcare, business, sports, traffic control, biology, drug discovery. The ‘behind-the-scenes’ tool enabling the power of Big Data – searching, sharing, visualizing, querying, analyzing – is the Semantic Web (aka ‘Web...